#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Efficiently mitigating human exposure to air pollution is a top public health objective .
2-1	16-27	Efficiently	_	_	_	_
2-2	28-38	mitigating	_	_	_	_
2-3	39-44	human	abstract[2]	new[2]	coref	3-13[9_2]
2-4	45-53	exposure	abstract[2]	new[2]	_	_
2-5	54-56	to	abstract[2]	new[2]	_	_
2-6	57-60	air	abstract[2]|abstract[3]	new[2]|new[3]	coref	3-15[10_3]
2-7	61-70	pollution	abstract[2]|abstract[3]	new[2]|new[3]	_	_
2-8	71-73	is	_	_	_	_
2-9	74-75	a	abstract[5]	new[5]	_	_
2-10	76-79	top	abstract[5]	new[5]	_	_
2-11	80-86	public	abstract[5]	new[5]	_	_
2-12	87-93	health	abstract|abstract[5]	new|new[5]	coref	4-34
2-13	94-103	objective	abstract[5]	new[5]	_	_
2-14	104-105	.	_	_	_	_

#Text=According to the most recent global burden of disease/comparative risk assessment , exposure to air pollution causes over 6.8 million premature deaths per year , with roughly equal contributions from ambient and household air pollution .
3-1	106-115	According	_	_	_	_
3-2	116-118	to	_	_	_	_
3-3	119-122	the	abstract[6]	new[6]	_	_
3-4	123-127	most	abstract[6]	new[6]	_	_
3-5	128-134	recent	abstract[6]	new[6]	_	_
3-6	135-141	global	abstract[6]	new[6]	_	_
3-7	142-148	burden	abstract[6]	new[6]	_	_
3-8	149-151	of	abstract[6]	new[6]	_	_
3-9	152-171	disease/comparative	abstract[6]|abstract[8]	new[6]|new[8]	coref	6-7[0_8]
3-10	172-176	risk	abstract[6]|abstract|abstract[8]	new[6]|new|new[8]	coref	17-25[144_0]
3-11	177-187	assessment	abstract[6]|abstract[8]	new[6]|new[8]	_	_
3-12	188-189	,	_	_	_	_
3-13	190-198	exposure	abstract[9]	giv[9]	coref	4-31[29_9]
3-14	199-201	to	abstract[9]	giv[9]	_	_
3-15	202-205	air	abstract[9]|abstract[10]	giv[9]|giv[10]	coref	3-33[17_10]
3-16	206-215	pollution	abstract[9]|abstract[10]	giv[9]|giv[10]	_	_
3-17	216-222	causes	_	_	_	_
3-18	223-227	over	event[11]	new[11]	_	_
3-19	228-231	6.8	event[11]	new[11]	_	_
3-20	232-239	million	event[11]	new[11]	_	_
3-21	240-249	premature	event[11]	new[11]	_	_
3-22	250-256	deaths	event[11]	new[11]	_	_
3-23	257-260	per	event[11]	new[11]	_	_
3-24	261-265	year	event[11]|time	new[11]|new	_	_
3-25	266-267	,	_	_	_	_
3-26	268-272	with	_	_	_	_
3-27	273-280	roughly	abstract[13]	new[13]	coref	11-16[90_13]
3-28	281-286	equal	abstract[13]	new[13]	_	_
3-29	287-300	contributions	abstract[13]	new[13]	_	_
3-30	301-305	from	abstract[13]	new[13]	_	_
3-31	306-313	ambient	abstract[13]|organization	new[13]|new	_	_
3-32	314-317	and	abstract[13]	new[13]	_	_
3-33	318-327	household	abstract[13]|place|abstract[17]	new[13]|new|giv[17]	coref|coref	4-11[0_17]|4-11[0_17]
3-34	328-331	air	abstract[13]|abstract|abstract[17]	new[13]|new|giv[17]	coref	4-10
3-35	332-341	pollution	abstract[13]|abstract[17]	new[13]|giv[17]	_	_
3-36	342-343	.	_	_	_	_

#Text=While many countries acknowledge this danger and have enacted air pollution prevention laws , developing specific rules and regulations to implement these laws can be challenging when the relationships between pollutant exposure and health effects are underspecified .
4-1	344-349	While	_	_	_	_
4-2	350-354	many	place[18]	new[18]	_	_
4-3	355-364	countries	place[18]	new[18]	_	_
4-4	365-376	acknowledge	_	_	_	_
4-5	377-381	this	abstract[19]	new[19]	_	_
4-6	382-388	danger	abstract[19]	new[19]	_	_
4-7	389-392	and	_	_	_	_
4-8	393-397	have	_	_	_	_
4-9	398-405	enacted	_	_	_	_
4-10	406-409	air	place|abstract[23]	giv|new[23]	coref|coref|coref|coref	4-22[26_23]|6-2|4-22[26_23]|6-2
4-11	410-419	pollution	abstract|abstract[23]	giv|new[23]	coref	6-3
4-12	420-430	prevention	abstract|abstract[23]	new|new[23]	_	_
4-13	431-435	laws	abstract[23]	new[23]	_	_
4-14	436-437	,	_	_	_	_
4-15	438-448	developing	_	_	_	_
4-16	449-457	specific	abstract[24]	new[24]	_	_
4-17	458-463	rules	abstract[24]	new[24]	_	_
4-18	464-467	and	_	_	_	_
4-19	468-479	regulations	abstract	new	_	_
4-20	480-482	to	_	_	_	_
4-21	483-492	implement	_	_	_	_
4-22	493-498	these	abstract[26]	giv[26]	_	_
4-23	499-503	laws	abstract[26]	giv[26]	_	_
4-24	504-507	can	_	_	_	_
4-25	508-510	be	_	_	_	_
4-26	511-522	challenging	_	_	_	_
4-27	523-527	when	_	_	_	_
4-28	528-531	the	abstract[27]	new[27]	coref	5-4[36_27]
4-29	532-545	relationships	abstract[27]	new[27]	_	_
4-30	546-553	between	abstract[27]	new[27]	_	_
4-31	554-563	pollutant	abstract[27]|abstract|abstract[29]|abstract[30]	new[27]|new|giv[29]|new[30]	coref|coref|coref|coref|coref|coref|coref|coref|coref	5-4[0_29]|8-3[66_30]|12-8[95_0]|5-4[0_29]|8-3[66_30]|12-8[95_0]|5-4[0_29]|8-3[66_30]|12-8[95_0]
4-32	564-572	exposure	abstract[27]|abstract[29]|abstract[30]	new[27]|giv[29]|new[30]	_	_
4-33	573-576	and	abstract[27]|abstract[30]	new[27]|new[30]	_	_
4-34	577-583	health	abstract[27]|abstract[30]|abstract|abstract[32]	new[27]|new[30]|giv|new[32]	coref|coref|coref|coref	5-29[41_0]|6-24[54_32]|5-29[41_0]|6-24[54_32]
4-35	584-591	effects	abstract[27]|abstract[30]|abstract[32]	new[27]|new[30]|new[32]	_	_
4-36	592-595	are	_	_	_	_
4-37	596-610	underspecified	_	_	_	_
4-38	611-612	.	_	_	_	_

#Text=Better information on exposure response relationships ( how clean is clean enough ? ) can help regulators more effectively balance the often competing objectives of economic growth and public health .
5-1	613-619	Better	abstract[33]	new[33]	coref	19-1[155_33]
5-2	620-631	information	abstract[33]	new[33]	_	_
5-3	632-634	on	abstract[33]	new[33]	_	_
5-4	635-643	exposure	abstract[33]|abstract|abstract[36]	new[33]|giv|giv[36]	coref|coref|coref|coref	6-6|7-18[61_36]|6-6|7-18[61_36]
5-5	644-652	response	abstract[33]|abstract|abstract[36]	new[33]|new|giv[36]	coref	16-29[135_0]
5-6	653-666	relationships	abstract[33]|abstract[36]	new[33]|giv[36]	_	_
5-7	667-668	(	_	_	_	_
5-8	669-672	how	_	_	_	_
5-9	673-678	clean	_	_	_	_
5-10	679-681	is	_	_	_	_
5-11	682-687	clean	_	_	_	_
5-12	688-694	enough	_	_	_	_
5-13	695-696	?	_	_	_	_
5-14	697-698	)	_	_	_	_
5-15	699-702	can	_	_	_	_
5-16	703-707	help	_	_	_	_
5-17	708-718	regulators	organization	new	_	_
5-18	719-723	more	_	_	_	_
5-19	724-735	effectively	_	_	_	_
5-20	736-743	balance	_	_	_	_
5-21	744-747	the	abstract[38]	new[38]	_	_
5-22	748-753	often	abstract[38]	new[38]	_	_
5-23	754-763	competing	abstract[38]	new[38]	_	_
5-24	764-774	objectives	abstract[38]	new[38]	_	_
5-25	775-777	of	abstract[38]	new[38]	_	_
5-26	778-786	economic	abstract[38]|abstract[39]|abstract[40]	new[38]|new[39]|new[40]	coref|coref	30-4[260_40]|30-4[260_40]
5-27	787-793	growth	abstract[38]|abstract[39]|abstract[40]	new[38]|new[39]|new[40]	_	_
5-28	794-797	and	abstract[38]|abstract[40]	new[38]|new[40]	_	_
5-29	798-804	public	abstract[38]|abstract[40]|abstract[41]	new[38]|new[40]|giv[41]	coref	6-25[0_41]
5-30	805-811	health	abstract[38]|abstract[40]|abstract[41]	new[38]|new[40]|giv[41]	_	_
5-31	812-813	.	_	_	_	_

#Text=In air pollution epidemiology , exposure assessment studies are the primary means for understanding links between exposure to chemical and physical agents and adverse health effects .
6-1	814-816	In	_	_	_	_
6-2	817-820	air	abstract|abstract[44]	giv|new[44]	coref|coref	14-6|14-6
6-3	821-830	pollution	abstract|abstract[44]	giv|new[44]	coref	14-7
6-4	831-843	epidemiology	abstract[44]	new[44]	_	_
6-5	844-845	,	_	_	_	_
6-6	846-854	exposure	abstract|event[47]	giv|new[47]	coref|coref|coref|coref	6-10[48_47]|6-17[51_0]|6-10[48_47]|6-17[51_0]
6-7	855-865	assessment	abstract|event[47]	giv|new[47]	coref	7-4
6-8	866-873	studies	event[47]	new[47]	_	_
6-9	874-877	are	_	_	_	_
6-10	878-881	the	event[48]	giv[48]	coref	7-3[57_48]
6-11	882-889	primary	event[48]	giv[48]	_	_
6-12	890-895	means	event[48]	giv[48]	_	_
6-13	896-899	for	_	_	_	_
6-14	900-913	understanding	abstract|abstract[50]	new|new[50]	_	_
6-15	914-919	links	abstract[50]	new[50]	_	_
6-16	920-927	between	abstract[50]	new[50]	_	_
6-17	928-936	exposure	abstract[50]|abstract[51]	new[50]|giv[51]	coref	7-3[0_51]
6-18	937-939	to	abstract[50]|abstract[51]	new[50]|giv[51]	_	_
6-19	940-948	chemical	abstract[50]|abstract[51]|substance[52]	new[50]|giv[51]|new[52]	_	_
6-20	949-952	and	abstract[50]|abstract[51]|substance[52]	new[50]|giv[51]|new[52]	_	_
6-21	953-961	physical	abstract[50]|abstract[51]|substance[52]	new[50]|giv[51]|new[52]	_	_
6-22	962-968	agents	abstract[50]|abstract[51]|substance[52]	new[50]|giv[51]|new[52]	_	_
6-23	969-972	and	abstract[50]|abstract[51]	new[50]|giv[51]	_	_
6-24	973-980	adverse	abstract[50]|abstract[51]|abstract[54]	new[50]|giv[51]|giv[54]	_	_
6-25	981-987	health	abstract[50]|abstract[51]|abstract|abstract[54]	new[50]|giv[51]|giv|giv[54]	coref	10-18
6-26	988-995	effects	abstract[50]|abstract[51]|abstract[54]	new[50]|giv[51]|giv[54]	_	_
6-27	996-997	.	_	_	_	_

#Text=However , exposure assessment studies have traditionally used imperfect proxies based on central site data to assess these relationships , even though ambient concentrations are poor predictors of personal exposure .
7-1	998-1005	However	_	_	_	_
7-2	1006-1007	,	_	_	_	_
7-3	1008-1016	exposure	abstract|event[57]	giv|giv[57]	coref|coref|coref|coref	7-29[64_0]|14-6[111_57]|7-29[64_0]|14-6[111_57]
7-4	1017-1027	assessment	abstract|event[57]	giv|giv[57]	coref	14-9
7-5	1028-1035	studies	event[57]	giv[57]	_	_
7-6	1036-1040	have	_	_	_	_
7-7	1041-1054	traditionally	_	_	_	_
7-8	1055-1059	used	_	_	_	_
7-9	1060-1069	imperfect	abstract[58]	new[58]	_	_
7-10	1070-1077	proxies	abstract[58]	new[58]	_	_
7-11	1078-1083	based	_	_	_	_
7-12	1084-1086	on	_	_	_	_
7-13	1087-1094	central	abstract[60]	new[60]	coref	14-17[113_60]
7-14	1095-1099	site	organization|abstract[60]	new|new[60]	_	_
7-15	1100-1104	data	abstract[60]	new[60]	_	_
7-16	1105-1107	to	_	_	_	_
7-17	1108-1114	assess	_	_	_	_
7-18	1115-1120	these	abstract[61]	giv[61]	_	_
7-19	1121-1134	relationships	abstract[61]	giv[61]	_	_
7-20	1135-1136	,	_	_	_	_
7-21	1137-1141	even	_	_	_	_
7-22	1142-1148	though	_	_	_	_
7-23	1149-1156	ambient	animal[62]	new[62]	coref	7-26[63_62]
7-24	1157-1171	concentrations	animal[62]	new[62]	_	_
7-25	1172-1175	are	_	_	_	_
7-26	1176-1180	poor	animal[63]	giv[63]	coref	9-18[0_63]
7-27	1181-1191	predictors	animal[63]	giv[63]	_	_
7-28	1192-1194	of	animal[63]	giv[63]	_	_
7-29	1195-1203	personal	animal[63]|abstract[64]	giv[63]|giv[64]	coref	8-3[65_64]
7-30	1204-1212	exposure	animal[63]|abstract[64]	giv[63]|giv[64]	_	_
7-31	1213-1214	.	_	_	_	_

#Text=For measuring personal exposure , ambient concentration readings from stationary sensors have many drawbacks .
8-1	1215-1218	For	_	_	_	_
8-2	1219-1228	measuring	_	_	_	_
8-3	1229-1237	personal	abstract[65]|abstract[66]	giv[65]|giv[66]	coref|coref|coref|coref	11-23[93_65]|29-27[254_66]|11-23[93_65]|29-27[254_66]
8-4	1238-1246	exposure	abstract[65]|abstract[66]	giv[65]|giv[66]	_	_
8-5	1247-1248	,	abstract[66]	giv[66]	_	_
8-6	1249-1256	ambient	abstract[66]|object[68]	giv[66]|new[68]	_	_
8-7	1257-1270	concentration	abstract[66]|abstract|object[68]	giv[66]|new|new[68]	coref	20-34[178_0]
8-8	1271-1279	readings	abstract[66]|object[68]	giv[66]|new[68]	_	_
8-9	1280-1284	from	abstract[66]|object[68]	giv[66]|new[68]	_	_
8-10	1285-1295	stationary	abstract[66]|object[68]|object[69]	giv[66]|new[68]|new[69]	coref	10-1[80_69]
8-11	1296-1303	sensors	abstract[66]|object[68]|object[69]	giv[66]|new[68]|new[69]	_	_
8-12	1304-1308	have	_	_	_	_
8-13	1309-1313	many	abstract[70]	new[70]	_	_
8-14	1314-1323	drawbacks	abstract[70]	new[70]	_	_
8-15	1324-1325	.	_	_	_	_

#Text=First , people move through multiple indoor and outdoor micro-environments with fine-scale spatial and temporal heterogeneity in concentrations , resulting in substantial person-to-person variation even among individuals living within the same building or neighborhood .
9-1	1326-1331	First	_	_	_	_
9-2	1332-1333	,	_	_	_	_
9-3	1334-1340	people	person	new	_	_
9-4	1341-1345	move	_	_	_	_
9-5	1346-1353	through	_	_	_	_
9-6	1354-1362	multiple	place[72]	new[72]	_	_
9-7	1363-1369	indoor	place[72]	new[72]	_	_
9-8	1370-1373	and	_	_	_	_
9-9	1374-1381	outdoor	place[73]	new[73]	_	_
9-10	1382-1400	micro-environments	place[73]	new[73]	_	_
9-11	1401-1405	with	place[73]	new[73]	_	_
9-12	1406-1416	fine-scale	place[73]|quantity[74]	new[73]|new[74]	coref	15-18[122_74]
9-13	1417-1424	spatial	place[73]|quantity[74]	new[73]|new[74]	_	_
9-14	1425-1428	and	place[73]|quantity[74]	new[73]|new[74]	_	_
9-15	1429-1437	temporal	place[73]|quantity[74]	new[73]|new[74]	_	_
9-16	1438-1451	heterogeneity	place[73]|quantity[74]	new[73]|new[74]	_	_
9-17	1452-1454	in	place[73]|quantity[74]	new[73]|new[74]	_	_
9-18	1455-1469	concentrations	place[73]|quantity[74]|animal	new[73]|new[74]|giv	coref	16-34[137_0]
9-19	1470-1471	,	_	_	_	_
9-20	1472-1481	resulting	_	_	_	_
9-21	1482-1484	in	_	_	_	_
9-22	1485-1496	substantial	abstract[76]	new[76]	_	_
9-23	1497-1513	person-to-person	abstract[76]	new[76]	_	_
9-24	1514-1523	variation	abstract[76]	new[76]	_	_
9-25	1524-1528	even	person[77]	new[77]	_	_
9-26	1529-1534	among	person[77]	new[77]	_	_
9-27	1535-1546	individuals	person[77]	new[77]	_	_
9-28	1547-1553	living	_	_	_	_
9-29	1554-1560	within	_	_	_	_
9-30	1561-1564	the	place[78]	new[78]	_	_
9-31	1565-1569	same	place[78]	new[78]	_	_
9-32	1570-1578	building	place[78]	new[78]	_	_
9-33	1579-1581	or	_	_	_	_
9-34	1582-1594	neighborhood	place	new	_	_
9-35	1595-1596	.	_	_	_	_

#Text=Stationary sensors are unable to capture these differences in daily routines and resulting exposures , potentially biasing health effect estimates .
10-1	1597-1607	Stationary	object[80]	giv[80]	coref	11-10[89_80]
10-2	1608-1615	sensors	object[80]	giv[80]	_	_
10-3	1616-1619	are	_	_	_	_
10-4	1620-1626	unable	_	_	_	_
10-5	1627-1629	to	_	_	_	_
10-6	1630-1637	capture	_	_	_	_
10-7	1638-1643	these	abstract[81]	new[81]	ana	11-6[0_81]
10-8	1644-1655	differences	abstract[81]	new[81]	_	_
10-9	1656-1658	in	abstract[81]	new[81]	_	_
10-10	1659-1664	daily	abstract[81]|abstract[82]	new[81]|new[82]	_	_
10-11	1665-1673	routines	abstract[81]|abstract[82]	new[81]|new[82]	_	_
10-12	1674-1677	and	abstract[81]	new[81]	_	_
10-13	1678-1687	resulting	abstract[81]|abstract[83]	new[81]|new[83]	coref	14-30[117_83]
10-14	1688-1697	exposures	abstract[81]|abstract[83]	new[81]|new[83]	_	_
10-15	1698-1699	,	_	_	_	_
10-16	1700-1711	potentially	_	_	_	_
10-17	1712-1719	biasing	_	_	_	_
10-18	1720-1726	health	abstract|abstract[86]	giv|new[86]	coref|coref|coref|coref	13-8|13-15[105_86]|13-8|13-15[105_86]
10-19	1727-1733	effect	abstract|abstract[86]	new|new[86]	_	_
10-20	1734-1743	estimates	abstract[86]	new[86]	_	_
10-21	1744-1745	.	_	_	_	_

#Text=In addition , due to their fixed nature , stationary sensors are unable to decouple the spatiotemporal contributions of individual sources to a person ’s exposure .
11-1	1746-1748	In	_	_	_	_
11-2	1749-1757	addition	_	_	_	_
11-3	1758-1759	,	_	_	_	_
11-4	1760-1763	due	_	_	_	_
11-5	1764-1766	to	_	_	_	_
11-6	1767-1772	their	abstract|abstract[88]	giv|new[88]	_	_
11-7	1773-1778	fixed	abstract[88]	new[88]	_	_
11-8	1779-1785	nature	abstract[88]	new[88]	_	_
11-9	1786-1787	,	_	_	_	_
11-10	1788-1798	stationary	object[89]	giv[89]	coref	15-2[118_89]
11-11	1799-1806	sensors	object[89]	giv[89]	_	_
11-12	1807-1810	are	_	_	_	_
11-13	1811-1817	unable	_	_	_	_
11-14	1818-1820	to	_	_	_	_
11-15	1821-1829	decouple	_	_	_	_
11-16	1830-1833	the	abstract[90]	giv[90]	_	_
11-17	1834-1848	spatiotemporal	abstract[90]	giv[90]	_	_
11-18	1849-1862	contributions	abstract[90]	giv[90]	_	_
11-19	1863-1865	of	abstract[90]	giv[90]	_	_
11-20	1866-1876	individual	abstract[90]|abstract[91]	giv[90]|new[91]	coref	24-38[206_91]
11-21	1877-1884	sources	abstract[90]|abstract[91]	giv[90]|new[91]	_	_
11-22	1885-1887	to	abstract[90]|abstract[91]	giv[90]|new[91]	_	_
11-23	1888-1889	a	abstract[90]|abstract[91]|abstract[93]	giv[90]|new[91]|giv[93]	coref	14-8[0_93]
11-24	1890-1896	person	abstract[90]|abstract[91]|person[92]|abstract[93]	giv[90]|new[91]|new[92]|giv[93]	_	_
11-25	1897-1899	’s	abstract[90]|abstract[91]|person[92]|abstract[93]	giv[90]|new[91]|new[92]|giv[93]	_	_
11-26	1900-1908	exposure	abstract[90]|abstract[91]|abstract[93]	giv[90]|new[91]|giv[93]	_	_
11-27	1909-1910	.	_	_	_	_

#Text=Finally , the actual inhaled dose of a pollutant is a function of respiration rate , and , thus , of physical activity patterns .
12-1	1911-1918	Finally	_	_	_	_
12-2	1919-1920	,	_	_	_	_
12-3	1921-1924	the	quantity[94]	new[94]	coref	12-11[96_94]
12-4	1925-1931	actual	quantity[94]	new[94]	_	_
12-5	1932-1939	inhaled	quantity[94]	new[94]	_	_
12-6	1940-1944	dose	quantity[94]	new[94]	_	_
12-7	1945-1947	of	quantity[94]	new[94]	_	_
12-8	1948-1949	a	quantity[94]|abstract[95]	new[94]|giv[95]	coref	14-31[0_95]
12-9	1950-1959	pollutant	quantity[94]|abstract[95]	new[94]|giv[95]	_	_
12-10	1960-1962	is	_	_	_	_
12-11	1963-1964	a	quantity[96]	giv[96]	_	_
12-12	1965-1973	function	quantity[96]	giv[96]	_	_
12-13	1974-1976	of	quantity[96]	giv[96]	_	_
12-14	1977-1988	respiration	quantity[96]|abstract|abstract[98]	giv[96]|new|new[98]	coref|coref	16-10|16-10
12-15	1989-1993	rate	quantity[96]|abstract[98]	giv[96]|new[98]	_	_
12-16	1994-1995	,	quantity[96]	giv[96]	_	_
12-17	1996-1999	and	quantity[96]	giv[96]	_	_
12-18	2000-2001	,	quantity[96]	giv[96]	_	_
12-19	2002-2006	thus	quantity[96]|abstract[100]	giv[96]|new[100]	coref	30-20[268_100]
12-20	2007-2008	,	quantity[96]|abstract[100]	giv[96]|new[100]	_	_
12-21	2009-2011	of	quantity[96]|abstract[100]	giv[96]|new[100]	_	_
12-22	2012-2020	physical	quantity[96]|abstract[100]	giv[96]|new[100]	_	_
12-23	2021-2029	activity	quantity[96]|abstract|abstract[100]	giv[96]|new|new[100]	coref	13-2[101_0]
12-24	2030-2038	patterns	quantity[96]|abstract[100]	giv[96]|new[100]	_	_
12-25	2039-2040	.	_	_	_	_

#Text=Since physical activity protects against many pollution-sensitive health outcomes , this may again confound average concentration-based estimates .
13-1	2041-2046	Since	_	_	_	_
13-2	2047-2055	physical	abstract[101]	giv[101]	ana	13-11[0_101]
13-3	2056-2064	activity	abstract[101]	giv[101]	_	_
13-4	2065-2073	protects	_	_	_	_
13-5	2074-2081	against	_	_	_	_
13-6	2082-2086	many	abstract[103]	new[103]	coref	31-13[277_103]
13-7	2087-2106	pollution-sensitive	abstract[103]	new[103]	_	_
13-8	2107-2113	health	abstract|abstract[103]	giv|new[103]	coref	29-30
13-9	2114-2122	outcomes	abstract[103]	new[103]	_	_
13-10	2123-2124	,	_	_	_	_
13-11	2125-2129	this	abstract	giv	coref	18-14[151_0]
13-12	2130-2133	may	_	_	_	_
13-13	2134-2139	again	_	_	_	_
13-14	2140-2148	confound	_	_	_	_
13-15	2149-2156	average	abstract[105]	giv[105]	_	_
13-16	2157-2176	concentration-based	abstract[105]	giv[105]	_	_
13-17	2177-2186	estimates	abstract[105]	giv[105]	_	_
13-18	2187-2188	.	_	_	_	_

#Text=To help address concerns with air pollution exposure assessment studies based on fixed , centrally located sensor data , researchers have proposed using wearable monitors to more accurately capture personalized pollutant exposures .
14-1	2189-2191	To	_	_	_	_
14-2	2192-2196	help	_	_	_	_
14-3	2197-2204	address	_	_	_	_
14-4	2205-2213	concerns	abstract[106]	new[106]	_	_
14-5	2214-2218	with	abstract[106]	new[106]	_	_
14-6	2219-2222	air	abstract[106]|abstract|event[111]	new[106]|giv|giv[111]	coref|coref	28-7[233_111]|28-7[233_111]
14-7	2223-2232	pollution	abstract[106]|abstract|event[111]	new[106]|giv|giv[111]	_	_
14-8	2233-2241	exposure	abstract[106]|abstract|event[111]	new[106]|giv|giv[111]	coref	16-5
14-9	2242-2252	assessment	abstract[106]|abstract|event[111]	new[106]|giv|giv[111]	coref	29-31
14-10	2253-2260	studies	abstract[106]|event[111]	new[106]|giv[111]	_	_
14-11	2261-2266	based	_	_	_	_
14-12	2267-2269	on	_	_	_	_
14-13	2270-2275	fixed	_	_	_	_
14-14	2276-2277	,	_	_	_	_
14-15	2278-2287	centrally	_	_	_	_
14-16	2288-2295	located	_	_	_	_
14-17	2296-2302	sensor	object|abstract[113]	new|giv[113]	coref|coref	16-4[127_113]|16-4[127_113]
14-18	2303-2307	data	abstract[113]	giv[113]	_	_
14-19	2308-2309	,	_	_	_	_
14-20	2310-2321	researchers	person	new	_	_
14-21	2322-2326	have	_	_	_	_
14-22	2327-2335	proposed	_	_	_	_
14-23	2336-2341	using	_	_	_	_
14-24	2342-2350	wearable	object[115]	new[115]	coref	15-5[119_115]
14-25	2351-2359	monitors	object[115]	new[115]	_	_
14-26	2360-2362	to	_	_	_	_
14-27	2363-2367	more	_	_	_	_
14-28	2368-2378	accurately	_	_	_	_
14-29	2379-2386	capture	_	_	_	_
14-30	2387-2399	personalized	abstract[117]	giv[117]	coref	15-10[0_117]
14-31	2400-2409	pollutant	abstract|abstract[117]	giv|giv[117]	coref	23-19
14-32	2410-2419	exposures	abstract[117]	giv[117]	_	_
14-33	2420-2421	.	_	_	_	_

#Text=Unlike stationary sensors , personal monitors can better capture exposures actually experienced by the wearers and provides the spatial and temporal heterogeneity necessary to design interventions incorporating human behaviors and lifestyle .
15-1	2422-2428	Unlike	_	_	_	_
15-2	2429-2439	stationary	object[118]	giv[118]	_	_
15-3	2440-2447	sensors	object[118]	giv[118]	_	_
15-4	2448-2449	,	_	_	_	_
15-5	2450-2458	personal	object[119]	giv[119]	_	_
15-6	2459-2467	monitors	object[119]	giv[119]	_	_
15-7	2468-2471	can	_	_	_	_
15-8	2472-2478	better	_	_	_	_
15-9	2479-2486	capture	_	_	_	_
15-10	2487-2496	exposures	abstract	giv	coref	28-4[232_0]
15-11	2497-2505	actually	_	_	_	_
15-12	2506-2517	experienced	_	_	_	_
15-13	2518-2520	by	_	_	_	_
15-14	2521-2524	the	person[121]	new[121]	_	_
15-15	2525-2532	wearers	person[121]	new[121]	_	_
15-16	2533-2536	and	_	_	_	_
15-17	2537-2545	provides	_	_	_	_
15-18	2546-2549	the	quantity[122]	giv[122]	_	_
15-19	2550-2557	spatial	quantity[122]	giv[122]	_	_
15-20	2558-2561	and	quantity[122]	giv[122]	_	_
15-21	2562-2570	temporal	quantity[122]	giv[122]	_	_
15-22	2571-2584	heterogeneity	quantity[122]	giv[122]	_	_
15-23	2585-2594	necessary	quantity[122]	giv[122]	_	_
15-24	2595-2597	to	quantity[122]	giv[122]	_	_
15-25	2598-2604	design	quantity[122]	giv[122]	_	_
15-26	2605-2618	interventions	quantity[122]|event	giv[122]|new	_	_
15-27	2619-2632	incorporating	quantity[122]	giv[122]	_	_
15-28	2633-2638	human	quantity[122]|abstract[124]	giv[122]|new[124]	_	_
15-29	2639-2648	behaviors	quantity[122]|abstract[124]	giv[122]|new[124]	_	_
15-30	2649-2652	and	quantity[122]	giv[122]	_	_
15-31	2653-2662	lifestyle	quantity[122]|abstract	giv[122]|new	ana	16-13
15-32	2663-2664	.	_	_	_	_

#Text=Furthermore , if personal exposure data is combined with respiration data , it becomes possible to estimate potential inhaled dose , a much higher fidelity measure for mapping the exposure response than using device concentrations alone .
16-1	2665-2676	Furthermore	_	_	_	_
16-2	2677-2678	,	_	_	_	_
16-3	2679-2681	if	_	_	_	_
16-4	2682-2690	personal	abstract[127]	giv[127]	coref	16-10[129_127]
16-5	2691-2699	exposure	abstract|abstract[127]	giv|giv[127]	coref	16-30
16-6	2700-2704	data	abstract[127]	giv[127]	_	_
16-7	2705-2707	is	_	_	_	_
16-8	2708-2716	combined	_	_	_	_
16-9	2717-2721	with	_	_	_	_
16-10	2722-2733	respiration	abstract|abstract[129]	giv|giv[129]	coref|coref|coref|coref	18-16[154_129]|24-32|18-16[154_129]|24-32
16-11	2734-2738	data	abstract[129]	giv[129]	_	_
16-12	2739-2740	,	_	_	_	_
16-13	2741-2743	it	abstract	giv	_	_
16-14	2744-2751	becomes	_	_	_	_
16-15	2752-2760	possible	_	_	_	_
16-16	2761-2763	to	_	_	_	_
16-17	2764-2772	estimate	_	_	_	_
16-18	2773-2782	potential	quantity[131]	new[131]	appos	16-22[133_131]
16-19	2783-2790	inhaled	quantity[131]	new[131]	_	_
16-20	2791-2795	dose	quantity[131]	new[131]	_	_
16-21	2796-2797	,	_	_	_	_
16-22	2798-2799	a	quantity[133]	giv[133]	coref	19-15[0_133]
16-23	2800-2804	much	quantity[133]	giv[133]	_	_
16-24	2805-2811	higher	quantity[133]	giv[133]	_	_
16-25	2812-2820	fidelity	organization|quantity[133]	new|giv[133]	_	_
16-26	2821-2828	measure	quantity[133]	giv[133]	_	_
16-27	2829-2832	for	_	_	_	_
16-28	2833-2840	mapping	_	_	_	_
16-29	2841-2844	the	abstract[135]	giv[135]	_	_
16-30	2845-2853	exposure	abstract|abstract[135]	giv|giv[135]	coref	18-19
16-31	2854-2862	response	abstract[135]	giv[135]	_	_
16-32	2863-2867	than	_	_	_	_
16-33	2868-2873	using	_	_	_	_
16-34	2874-2880	device	object|animal[137]	new|giv[137]	coref|coref|coref|coref	19-19[160_0]|25-47[218_137]|19-19[160_0]|25-47[218_137]
16-35	2881-2895	concentrations	animal[137]	giv[137]	_	_
16-36	2896-2901	alone	_	_	_	_
16-37	2902-2903	.	_	_	_	_

#Text=However , passively measuring respiratory rates is not always possible without subjects wearing additional devices , increasing the level of study complexity and increasing the risk of protocol non-compliance .
17-1	2904-2911	However	_	_	_	_
17-2	2912-2913	,	_	_	_	_
17-3	2914-2923	passively	_	_	_	_
17-4	2924-2933	measuring	_	_	_	_
17-5	2934-2945	respiratory	abstract[138]	new[138]	coref	19-10[157_138]
17-6	2946-2951	rates	abstract[138]	new[138]	_	_
17-7	2952-2954	is	_	_	_	_
17-8	2955-2958	not	_	_	_	_
17-9	2959-2965	always	_	_	_	_
17-10	2966-2974	possible	_	_	_	_
17-11	2975-2982	without	_	_	_	_
17-12	2983-2991	subjects	person	new	_	_
17-13	2992-2999	wearing	_	_	_	_
17-14	3000-3010	additional	object[140]	new[140]	_	_
17-15	3011-3018	devices	object[140]	new[140]	_	_
17-16	3019-3020	,	_	_	_	_
17-17	3021-3031	increasing	_	_	_	_
17-18	3032-3035	the	abstract[141]	new[141]	_	_
17-19	3036-3041	level	abstract[141]	new[141]	_	_
17-20	3042-3044	of	abstract[141]	new[141]	_	_
17-21	3045-3050	study	abstract[141]|abstract|abstract[143]	new[141]|new|new[143]	coref|coref	18-2[146_0]|18-2[146_0]
17-22	3051-3061	complexity	abstract[141]|abstract[143]	new[141]|new[143]	_	_
17-23	3062-3065	and	_	_	_	_
17-24	3066-3076	increasing	_	_	_	_
17-25	3077-3080	the	abstract[144]	giv[144]	_	_
17-26	3081-3085	risk	abstract[144]	giv[144]	_	_
17-27	3086-3088	of	abstract[144]	giv[144]	_	_
17-28	3089-3097	protocol	abstract[144]|abstract	giv[144]|new	_	_
17-29	3098-3112	non-compliance	abstract[144]	giv[144]	_	_
17-30	3113-3114	.	_	_	_	_

#Text=In this study , we focus on classification methods for determining levels of high activity directly from wearable exposure monitor data .
18-1	3115-3117	In	_	_	_	_
18-2	3118-3122	this	abstract[146]	giv[146]	coref	26-1[220_146]
18-3	3123-3128	study	abstract[146]	giv[146]	_	_
18-4	3129-3130	,	_	_	_	_
18-5	3131-3133	we	person	acc	ana	20-3
18-6	3134-3139	focus	abstract	new	coref|none	23-1[184_0]|18-6[0_184]
18-7	3140-3142	on	_	_	_	_
18-8	3143-3157	classification	abstract|abstract[149]	new|new[149]	_	_
18-9	3158-3165	methods	abstract[149]	new[149]	_	_
18-10	3166-3169	for	_	_	_	_
18-11	3170-3181	determining	_	_	_	_
18-12	3182-3188	levels	abstract[150]	new[150]	_	_
18-13	3189-3191	of	abstract[150]	new[150]	_	_
18-14	3192-3196	high	abstract[150]|abstract[151]	new[150]|giv[151]	coref	20-13[169_151]
18-15	3197-3205	activity	abstract[150]|abstract[151]	new[150]|giv[151]	_	_
18-16	3206-3214	directly	abstract[154]	giv[154]	coref	20-18[170_154]
18-17	3215-3219	from	abstract[154]	giv[154]	_	_
18-18	3220-3228	wearable	abstract[154]	giv[154]	_	_
18-19	3229-3237	exposure	abstract|abstract[154]	giv|giv[154]	coref	19-26
18-20	3238-3245	monitor	object|abstract[154]	new|giv[154]	coref	20-20[174_0]
18-21	3246-3250	data	abstract[154]	giv[154]	_	_
18-22	3251-3252	.	_	_	_	_

#Text=This information can be used to develop tiers of respiratory rates for potential inhaled dose calculations , using the same wearable device required for personal exposure monitoring .
19-1	3253-3257	This	abstract[155]	giv[155]	_	_
19-2	3258-3269	information	abstract[155]	giv[155]	_	_
19-3	3270-3273	can	_	_	_	_
19-4	3274-3276	be	_	_	_	_
19-5	3277-3281	used	_	_	_	_
19-6	3282-3284	to	_	_	_	_
19-7	3285-3292	develop	_	_	_	_
19-8	3293-3298	tiers	abstract[156]	new[156]	_	_
19-9	3299-3301	of	abstract[156]	new[156]	_	_
19-10	3302-3313	respiratory	abstract[156]|abstract[157]	new[156]|giv[157]	coref	24-30[203_157]
19-11	3314-3319	rates	abstract[156]|abstract[157]	new[156]|giv[157]	_	_
19-12	3320-3323	for	abstract[156]|abstract[157]	new[156]|giv[157]	_	_
19-13	3324-3333	potential	abstract[156]|abstract[157]|abstract[159]	new[156]|giv[157]|new[159]	_	_
19-14	3334-3341	inhaled	abstract[156]|abstract[157]|abstract[159]	new[156]|giv[157]|new[159]	_	_
19-15	3342-3346	dose	abstract[156]|abstract[157]|quantity|abstract[159]	new[156]|giv[157]|giv|new[159]	coref	24-13[198_0]
19-16	3347-3359	calculations	abstract[156]|abstract[157]|abstract[159]	new[156]|giv[157]|new[159]	_	_
19-17	3360-3361	,	_	_	_	_
19-18	3362-3367	using	_	_	_	_
19-19	3368-3371	the	object[160]	giv[160]	_	_
19-20	3372-3376	same	object[160]	giv[160]	_	_
19-21	3377-3385	wearable	object[160]	giv[160]	_	_
19-22	3386-3392	device	object[160]	giv[160]	_	_
19-23	3393-3401	required	_	_	_	_
19-24	3402-3405	for	_	_	_	_
19-25	3406-3414	personal	abstract[162]	new[162]	_	_
19-26	3415-3423	exposure	abstract|abstract[162]	giv|new[162]	coref	20-24
19-27	3424-3434	monitoring	abstract[162]	new[162]	_	_
19-28	3435-3436	.	_	_	_	_

#Text=Specifically , we develop a machine learning model for identifying periods of bicycling activity using passively collected data from the RTI MicroPEM wearable exposure monitor , a lightweight device capable of continuously sampling both particulate matter concentration and the wearer ’s acceleration .
20-1	3437-3449	Specifically	_	_	_	_
20-2	3450-3451	,	_	_	_	_
20-3	3452-3454	we	person	giv	ana	23-1
20-4	3455-3462	develop	_	_	_	_
20-5	3463-3464	a	abstract[166]	new[166]	_	_
20-6	3465-3472	machine	object|abstract[166]	new|new[166]	_	_
20-7	3473-3481	learning	abstract|abstract[166]	new|new[166]	_	_
20-8	3482-3487	model	abstract[166]	new[166]	_	_
20-9	3488-3491	for	_	_	_	_
20-10	3492-3503	identifying	_	_	_	_
20-11	3504-3511	periods	time[167]	new[167]	coref	23-5[185_167]
20-12	3512-3514	of	time[167]	new[167]	_	_
20-13	3515-3524	bicycling	time[167]|organization|abstract[169]	new[167]|new|giv[169]	coref|coref|coref|coref	23-7|23-7[187_169]|23-7|23-7[187_169]
20-14	3525-3533	activity	time[167]|abstract[169]	new[167]|giv[169]	_	_
20-15	3534-3539	using	_	_	_	_
20-16	3540-3549	passively	_	_	_	_
20-17	3550-3559	collected	_	_	_	_
20-18	3560-3564	data	abstract[170]	giv[170]	_	_
20-19	3565-3569	from	abstract[170]	giv[170]	_	_
20-20	3570-3573	the	abstract[170]|object[174]	giv[170]|giv[174]	appos	20-27[175_174]
20-21	3574-3577	RTI	abstract[170]|object|object[174]	giv[170]|new|giv[174]	_	_
20-22	3578-3586	MicroPEM	abstract[170]|abstract|object[174]	giv[170]|new|giv[174]	_	_
20-23	3587-3595	wearable	abstract[170]|object[174]	giv[170]|giv[174]	_	_
20-24	3596-3604	exposure	abstract[170]|abstract|object[174]	giv[170]|giv|giv[174]	coref	23-19[191_0]
20-25	3605-3612	monitor	abstract[170]|object[174]	giv[170]|giv[174]	_	_
20-26	3613-3614	,	_	_	_	_
20-27	3615-3616	a	object[175]	giv[175]	_	_
20-28	3617-3628	lightweight	object[175]	giv[175]	_	_
20-29	3629-3635	device	object[175]	giv[175]	_	_
20-30	3636-3643	capable	object[175]	giv[175]	_	_
20-31	3644-3646	of	_	_	_	_
20-32	3647-3659	continuously	_	_	_	_
20-33	3660-3668	sampling	_	_	_	_
20-34	3669-3673	both	abstract[178]	giv[178]	_	_
20-35	3674-3685	particulate	abstract|abstract[178]	new|giv[178]	_	_
20-36	3686-3692	matter	event|abstract[178]	new|giv[178]	_	_
20-37	3693-3706	concentration	abstract[178]	giv[178]	_	_
20-38	3707-3710	and	_	_	_	_
20-39	3711-3714	the	abstract[180]	new[180]	_	_
20-40	3715-3721	wearer	person[179]|abstract[180]	new[179]|new[180]	_	_
20-41	3722-3724	’s	person[179]|abstract[180]	new[179]|new[180]	_	_
20-42	3725-3737	acceleration	abstract[180]	new[180]	_	_
20-43	3738-3739	.	_	_	_	_

#Text=1.1 .
21-1	3740-3743	1.1	abstract	new	_	_
21-2	3744-3745	.	_	_	_	_

#Text=Motivation
22-1	3746-3756	Motivation	abstract	new	_	_

#Text=Our focus on identifying periods of bicycling activity is motivated by the elevated risk of urban cyclists for pollutant exposure when compared to other urban residents .
23-1	3757-3760	Our	person|abstract[184]	giv|new[184]	_	_
23-2	3761-3766	focus	abstract[184]	new[184]	_	_
23-3	3767-3769	on	_	_	_	_
23-4	3770-3781	identifying	_	_	_	_
23-5	3782-3789	periods	time[185]	giv[185]	_	_
23-6	3790-3792	of	time[185]	giv[185]	_	_
23-7	3793-3802	bicycling	time[185]|abstract|abstract[187]	giv[185]|giv|giv[187]	coref|coref	28-37|28-37
23-8	3803-3811	activity	time[185]|abstract[187]	giv[185]|giv[187]	_	_
23-9	3812-3814	is	_	_	_	_
23-10	3815-3824	motivated	_	_	_	_
23-11	3825-3827	by	_	_	_	_
23-12	3828-3831	the	abstract[188]	new[188]	_	_
23-13	3832-3840	elevated	abstract[188]	new[188]	_	_
23-14	3841-3845	risk	abstract[188]	new[188]	_	_
23-15	3846-3848	of	abstract[188]	new[188]	_	_
23-16	3849-3854	urban	abstract[188]|person[189]	new[188]|new[189]	coref	24-2[193_189]
23-17	3855-3863	cyclists	abstract[188]|person[189]	new[188]|new[189]	_	_
23-18	3864-3867	for	abstract[188]|person[189]	new[188]|new[189]	_	_
23-19	3868-3877	pollutant	abstract[188]|person[189]|abstract|abstract[191]	new[188]|new[189]|giv|giv[191]	coref|coref	29-27[253_191]|29-27[253_191]
23-20	3878-3886	exposure	abstract[188]|person[189]|abstract[191]	new[188]|new[189]|giv[191]	_	_
23-21	3887-3891	when	_	_	_	_
23-22	3892-3900	compared	_	_	_	_
23-23	3901-3903	to	_	_	_	_
23-24	3904-3909	other	person[192]	new[192]	coref	24-22[199_192]
23-25	3910-3915	urban	person[192]	new[192]	_	_
23-26	3916-3925	residents	person[192]	new[192]	_	_
23-27	3926-3927	.	_	_	_	_

#Text=Since urban cyclists undertake strenuous exercise in close proximity to traffic , their potential dose is likely to be higher than many other urban residents , due both to their increased respiration rates and their proximity to traffic sources .
24-1	3928-3933	Since	_	_	_	_
24-2	3934-3939	urban	person[193]	giv[193]	ana	24-13[0_193]
24-3	3940-3948	cyclists	person[193]	giv[193]	_	_
24-4	3949-3958	undertake	_	_	_	_
24-5	3959-3968	strenuous	event[194]	new[194]	coref	32-2[279_194]
24-6	3969-3977	exercise	event[194]	new[194]	_	_
24-7	3978-3980	in	_	_	_	_
24-8	3981-3986	close	abstract[195]	new[195]	ana	24-28[200_195]
24-9	3987-3996	proximity	abstract[195]	new[195]	_	_
24-10	3997-3999	to	abstract[195]	new[195]	_	_
24-11	4000-4007	traffic	abstract[195]|place	new[195]|new	coref	24-38
24-12	4008-4009	,	_	_	_	_
24-13	4010-4015	their	person|quantity[198]	giv|giv[198]	ana|coref|ana|coref	24-30|26-5[221_198]|24-30|26-5[221_198]
24-14	4016-4025	potential	quantity[198]	giv[198]	_	_
24-15	4026-4030	dose	quantity[198]	giv[198]	_	_
24-16	4031-4033	is	_	_	_	_
24-17	4034-4040	likely	_	_	_	_
24-18	4041-4043	to	_	_	_	_
24-19	4044-4046	be	_	_	_	_
24-20	4047-4053	higher	_	_	_	_
24-21	4054-4058	than	_	_	_	_
24-22	4059-4063	many	person[199]	giv[199]	_	_
24-23	4064-4069	other	person[199]	giv[199]	_	_
24-24	4070-4075	urban	person[199]	giv[199]	_	_
24-25	4076-4085	residents	person[199]	giv[199]	_	_
24-26	4086-4087	,	person[199]	giv[199]	_	_
24-27	4088-4091	due	person[199]	giv[199]	_	_
24-28	4092-4096	both	person[199]|abstract[200]	giv[199]|giv[200]	_	_
24-29	4097-4099	to	person[199]|abstract[200]	giv[199]|giv[200]	_	_
24-30	4100-4105	their	person[199]|abstract[200]|person|abstract[203]	giv[199]|giv[200]|giv|giv[203]	ana|ana	24-35|24-35
24-31	4106-4115	increased	person[199]|abstract[200]|abstract[203]	giv[199]|giv[200]|giv[203]	_	_
24-32	4116-4127	respiration	person[199]|abstract[200]|abstract|abstract[203]	giv[199]|giv[200]|giv|giv[203]	_	_
24-33	4128-4133	rates	person[199]|abstract[200]|abstract[203]	giv[199]|giv[200]|giv[203]	_	_
24-34	4134-4137	and	person[199]|abstract[200]|abstract[203]	giv[199]|giv[200]|giv[203]	_	_
24-35	4138-4143	their	person[199]|abstract[200]|abstract[203]|person	giv[199]|giv[200]|giv[203]|giv	coref	25-8
24-36	4144-4153	proximity	person[199]|abstract[200]|abstract[203]	giv[199]|giv[200]|giv[203]	_	_
24-37	4154-4156	to	person[199]|abstract[200]|abstract[203]	giv[199]|giv[200]|giv[203]	_	_
24-38	4157-4164	traffic	person[199]|abstract[200]|abstract[203]|abstract|abstract[206]	giv[199]|giv[200]|giv[203]|giv|giv[206]	coref|coref	29-16|29-16
24-39	4165-4172	sources	person[199]|abstract[200]|abstract[203]|abstract[206]	giv[199]|giv[200]|giv[203]|giv[206]	_	_
24-40	4173-4174	.	_	_	_	_

#Text=For example , Zuurbier et al. estimated cyclists inhale twice as much ultra fine particle ( UFP counts ) and PM2.5 ( mass ) per unit time as car and bus occupants because of their much higher minute ventilation , even though the measured UFP and PM concentrations were higher inside the vehicles .
25-1	4175-4178	For	_	_	_	_
25-2	4179-4186	example	_	_	_	_
25-3	4187-4188	,	_	_	_	_
25-4	4189-4197	Zuurbier	person	new	_	_
25-5	4198-4200	et	_	_	_	_
25-6	4201-4204	al.	_	_	_	_
25-7	4205-4214	estimated	_	_	_	_
25-8	4215-4223	cyclists	person	giv	ana	25-35
25-9	4224-4230	inhale	_	_	_	_
25-10	4231-4236	twice	_	_	_	_
25-11	4237-4239	as	_	_	_	_
25-12	4240-4244	much	_	_	_	_
25-13	4245-4250	ultra	_	_	_	_
25-14	4251-4255	fine	_	_	_	_
25-15	4256-4264	particle	_	_	_	_
25-16	4265-4266	(	_	_	_	_
25-17	4267-4270	UFP	organization|object[210]	new|new[210]	coref|coref	25-43[217_0]|25-43[217_0]
25-18	4271-4277	counts	object[210]	new[210]	_	_
25-19	4278-4279	)	_	_	_	_
25-20	4280-4283	and	_	_	_	_
25-21	4284-4289	PM2.5	_	_	_	_
25-22	4290-4291	(	_	_	_	_
25-23	4292-4296	mass	quantity	new	_	_
25-24	4297-4298	)	_	_	_	_
25-25	4299-4302	per	_	_	_	_
25-26	4303-4307	unit	object|time[213]	new|new[213]	_	_
25-27	4308-4312	time	time[213]	new[213]	_	_
25-28	4313-4315	as	time[213]	new[213]	_	_
25-29	4316-4319	car	time[213]	new[213]	_	_
25-30	4320-4323	and	time[213]	new[213]	_	_
25-31	4324-4327	bus	time[213]|object	new[213]|new	_	_
25-32	4328-4337	occupants	time[213]	new[213]	_	_
25-33	4338-4345	because	time[213]	new[213]	_	_
25-34	4346-4348	of	time[213]	new[213]	_	_
25-35	4349-4354	their	time[213]|person|abstract[216]	new[213]|giv|new[216]	coref|coref|coref|coref	26-10|27-9[227_216]|26-10|27-9[227_216]
25-36	4355-4359	much	time[213]|abstract[216]	new[213]|new[216]	_	_
25-37	4360-4366	higher	time[213]|abstract[216]	new[213]|new[216]	_	_
25-38	4367-4373	minute	time[213]|abstract[216]	new[213]|new[216]	_	_
25-39	4374-4385	ventilation	time[213]|abstract[216]	new[213]|new[216]	_	_
25-40	4386-4387	,	_	_	_	_
25-41	4388-4392	even	_	_	_	_
25-42	4393-4399	though	_	_	_	_
25-43	4400-4403	the	organization[217]	giv[217]	_	_
25-44	4404-4412	measured	organization[217]	giv[217]	_	_
25-45	4413-4416	UFP	organization[217]	giv[217]	_	_
25-46	4417-4420	and	_	_	_	_
25-47	4421-4423	PM	animal[218]	giv[218]	_	_
25-48	4424-4438	concentrations	animal[218]	giv[218]	_	_
25-49	4439-4443	were	_	_	_	_
25-50	4444-4450	higher	_	_	_	_
25-51	4451-4457	inside	_	_	_	_
25-52	4458-4461	the	object[219]	new[219]	_	_
25-53	4462-4470	vehicles	object[219]	new[219]	_	_
25-54	4471-4472	.	_	_	_	_

#Text=A similar study found the average daily dose of cyclists was 1.06 – 1.30 times higher than non-cyclists .
26-1	4473-4474	A	abstract[220]	giv[220]	_	_
26-2	4475-4482	similar	abstract[220]	giv[220]	_	_
26-3	4483-4488	study	abstract[220]	giv[220]	_	_
26-4	4489-4494	found	_	_	_	_
26-5	4495-4498	the	quantity[221]	giv[221]	coref	27-1[226_221]
26-6	4499-4506	average	quantity[221]	giv[221]	_	_
26-7	4507-4512	daily	quantity[221]	giv[221]	_	_
26-8	4513-4517	dose	quantity[221]	giv[221]	_	_
26-9	4518-4520	of	quantity[221]	giv[221]	_	_
26-10	4521-4529	cyclists	quantity[221]|person	giv[221]|giv	coref	27-14[228_0]
26-11	4530-4533	was	_	_	_	_
26-12	4534-4538	1.06	quantity	new	_	_
26-13	4539-4540	–	_	_	_	_
26-14	4541-4545	1.30	quantity[224]	new[224]	_	_
26-15	4546-4551	times	quantity[224]	new[224]	_	_
26-16	4552-4558	higher	_	_	_	_
26-17	4559-4563	than	_	_	_	_
26-18	4564-4576	non-cyclists	person	new	_	_
26-19	4577-4578	.	_	_	_	_

#Text=This larger inhaled dose is likely due to the average minute ventilation of cyclists being 4.3 times higher than vehicle passengers .
27-1	4579-4583	This	quantity[226]	giv[226]	_	_
27-2	4584-4590	larger	quantity[226]	giv[226]	_	_
27-3	4591-4598	inhaled	quantity[226]	giv[226]	_	_
27-4	4599-4603	dose	quantity[226]	giv[226]	_	_
27-5	4604-4606	is	_	_	_	_
27-6	4607-4613	likely	_	_	_	_
27-7	4614-4617	due	_	_	_	_
27-8	4618-4620	to	_	_	_	_
27-9	4621-4624	the	abstract[227]	giv[227]	_	_
27-10	4625-4632	average	abstract[227]	giv[227]	_	_
27-11	4633-4639	minute	abstract[227]	giv[227]	_	_
27-12	4640-4651	ventilation	abstract[227]	giv[227]	_	_
27-13	4652-4654	of	abstract[227]	giv[227]	_	_
27-14	4655-4663	cyclists	abstract[227]|person[228]	giv[227]|giv[228]	coref	29-8[0_228]
27-15	4664-4669	being	abstract[227]|person[228]	giv[227]|giv[228]	_	_
27-16	4670-4673	4.3	abstract[227]|person[228]|quantity[229]	giv[227]|giv[228]|new[229]	_	_
27-17	4674-4679	times	abstract[227]|person[228]|quantity[229]	giv[227]|giv[228]|new[229]	_	_
27-18	4680-4686	higher	abstract[227]|person[228]	giv[227]|giv[228]	_	_
27-19	4687-4691	than	_	_	_	_
27-20	4692-4699	vehicle	object|person[231]	new|new[231]	_	_
27-21	4700-4710	passengers	person[231]	new[231]	_	_
27-22	4711-4712	.	_	_	_	_

#Text=In terms of potential exposures , recent studies in major North American cities have found average exposures along bike routes to be higher than comparable fixed sidewalk stations and significant associations between higher PM2.5 emissions and bicycling volume .
28-1	4713-4715	In	_	_	_	_
28-2	4716-4721	terms	_	_	_	_
28-3	4722-4724	of	_	_	_	_
28-4	4725-4734	potential	abstract[232]	giv[232]	coref	28-16[235_232]
28-5	4735-4744	exposures	abstract[232]	giv[232]	_	_
28-6	4745-4746	,	_	_	_	_
28-7	4747-4753	recent	event[233]	giv[233]	_	_
28-8	4754-4761	studies	event[233]	giv[233]	_	_
28-9	4762-4764	in	event[233]	giv[233]	_	_
28-10	4765-4770	major	event[233]|place[234]	giv[233]|new[234]	coref	30-15[265_234]
28-11	4771-4776	North	event[233]|place[234]	giv[233]|new[234]	_	_
28-12	4777-4785	American	event[233]|place[234]	giv[233]|new[234]	_	_
28-13	4786-4792	cities	event[233]|place[234]	giv[233]|new[234]	_	_
28-14	4793-4797	have	_	_	_	_
28-15	4798-4803	found	_	_	_	_
28-16	4804-4811	average	abstract[235]	giv[235]	_	_
28-17	4812-4821	exposures	abstract[235]	giv[235]	_	_
28-18	4822-4827	along	abstract[235]	giv[235]	_	_
28-19	4828-4832	bike	abstract[235]|object|object[237]	giv[235]|new|new[237]	_	_
28-20	4833-4839	routes	abstract[235]|object[237]	giv[235]|new[237]	_	_
28-21	4840-4842	to	_	_	_	_
28-22	4843-4845	be	_	_	_	_
28-23	4846-4852	higher	_	_	_	_
28-24	4853-4857	than	_	_	_	_
28-25	4858-4868	comparable	place[239]	new[239]	_	_
28-26	4869-4874	fixed	place[239]	new[239]	_	_
28-27	4875-4883	sidewalk	place|place[239]	new|new[239]	_	_
28-28	4884-4892	stations	place[239]	new[239]	_	_
28-29	4893-4896	and	_	_	_	_
28-30	4897-4908	significant	abstract[240]	new[240]	_	_
28-31	4909-4921	associations	abstract[240]	new[240]	_	_
28-32	4922-4929	between	abstract[240]	new[240]	_	_
28-33	4930-4936	higher	abstract[240]|abstract[242]	new[240]|new[242]	_	_
28-34	4937-4942	PM2.5	abstract[240]|abstract|abstract[242]	new[240]|new|new[242]	_	_
28-35	4943-4952	emissions	abstract[240]|abstract[242]	new[240]|new[242]	_	_
28-36	4953-4956	and	abstract[240]	new[240]	_	_
28-37	4957-4966	bicycling	abstract[240]|organization|object[244]	new[240]|giv|new[244]	_	_
28-38	4967-4973	volume	abstract[240]|object[244]	new[240]|new[244]	_	_
28-39	4974-4975	.	_	_	_	_

#Text=Pedestrians and joggers , in addition to cyclists , receive higher potential inhaled doses of traffic related pollutants , but cyclists are the preferred cohort because the exposure and health assessment equipment is less burdensome for cyclists to carry .
29-1	4976-4987	Pedestrians	person	new	_	_
29-2	4988-4991	and	_	_	_	_
29-3	4992-4999	joggers	person[246]	new[246]	_	_
29-4	5000-5001	,	person[246]	new[246]	_	_
29-5	5002-5004	in	person[246]	new[246]	_	_
29-6	5005-5013	addition	person[246]	new[246]	_	_
29-7	5014-5016	to	person[246]	new[246]	_	_
29-8	5017-5025	cyclists	person[246]|person	new[246]|giv	coref	29-21
29-9	5026-5027	,	_	_	_	_
29-10	5028-5035	receive	_	_	_	_
29-11	5036-5042	higher	abstract[248]	new[248]	_	_
29-12	5043-5052	potential	abstract[248]	new[248]	_	_
29-13	5053-5060	inhaled	abstract[248]	new[248]	_	_
29-14	5061-5066	doses	abstract[248]	new[248]	_	_
29-15	5067-5069	of	abstract[248]	new[248]	_	_
29-16	5070-5077	traffic	abstract[248]|abstract	new[248]|giv	_	_
29-17	5078-5085	related	abstract[248]|object[250]	new[248]|new[250]	_	_
29-18	5086-5096	pollutants	abstract[248]|object[250]	new[248]|new[250]	_	_
29-19	5097-5098	,	_	_	_	_
29-20	5099-5102	but	_	_	_	_
29-21	5103-5111	cyclists	person	giv	coref	29-37
29-22	5112-5115	are	_	_	_	_
29-23	5116-5119	the	abstract[252]	new[252]	_	_
29-24	5120-5129	preferred	abstract[252]	new[252]	_	_
29-25	5130-5136	cohort	abstract[252]	new[252]	_	_
29-26	5137-5144	because	_	_	_	_
29-27	5145-5148	the	abstract[253]|abstract[254]	giv[253]|giv[254]	coref|coref	30-21[0_253]|30-21[0_253]
29-28	5149-5157	exposure	abstract[253]|abstract[254]	giv[253]|giv[254]	_	_
29-29	5158-5161	and	abstract[254]	giv[254]	_	_
29-30	5162-5168	health	abstract[254]|abstract|object[257]	giv[254]|giv|new[257]	coref|coref	31-8[274_0]|31-8[274_0]
29-31	5169-5179	assessment	abstract[254]|abstract|object[257]	giv[254]|giv|new[257]	_	_
29-32	5180-5189	equipment	abstract[254]|object[257]	giv[254]|new[257]	_	_
29-33	5190-5192	is	_	_	_	_
29-34	5193-5197	less	_	_	_	_
29-35	5198-5208	burdensome	_	_	_	_
29-36	5209-5212	for	_	_	_	_
29-37	5213-5221	cyclists	person	giv	_	_
29-38	5222-5224	to	_	_	_	_
29-39	5225-5230	carry	_	_	_	_
29-40	5231-5232	.	_	_	_	_

#Text=Lastly , given the growth in ridership and infrastructural support for urban cycling in many U.S. cities , understanding cyclist exposure patterns can help address many practical issues of concern to the public .
30-1	5233-5239	Lastly	_	_	_	_
30-2	5240-5241	,	_	_	_	_
30-3	5242-5247	given	_	_	_	_
30-4	5248-5251	the	abstract[259]|abstract[260]	new[259]|giv[260]	_	_
30-5	5252-5258	growth	abstract[259]|abstract[260]	new[259]|giv[260]	_	_
30-6	5259-5261	in	abstract[259]|abstract[260]	new[259]|giv[260]	_	_
30-7	5262-5271	ridership	abstract[259]|abstract[260]|person	new[259]|giv[260]|new	_	_
30-8	5272-5275	and	abstract[260]	giv[260]	_	_
30-9	5276-5291	infrastructural	abstract[260]|abstract[262]	giv[260]|new[262]	_	_
30-10	5292-5299	support	abstract[260]|abstract[262]	giv[260]|new[262]	_	_
30-11	5300-5303	for	abstract[260]|abstract[262]	giv[260]|new[262]	_	_
30-12	5304-5309	urban	abstract[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
30-13	5310-5317	cycling	abstract[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
30-14	5318-5320	in	abstract[260]|abstract[262]|abstract[263]	giv[260]|new[262]|new[263]	_	_
30-15	5321-5325	many	abstract[260]|abstract[262]|abstract[263]|place[265]	giv[260]|new[262]|new[263]|giv[265]	_	_
30-16	5326-5330	U.S.	abstract[260]|abstract[262]|abstract[263]|place|place[265]	giv[260]|new[262]|new[263]|new|giv[265]	_	_
30-17	5331-5337	cities	abstract[260]|abstract[262]|abstract[263]|place[265]	giv[260]|new[262]|new[263]|giv[265]	_	_
30-18	5338-5339	,	_	_	_	_
30-19	5340-5353	understanding	_	_	_	_
30-20	5354-5361	cyclist	person|abstract[268]	new|giv[268]	_	_
30-21	5362-5370	exposure	abstract|abstract[268]	giv|giv[268]	_	_
30-22	5371-5379	patterns	abstract[268]	giv[268]	_	_
30-23	5380-5383	can	_	_	_	_
30-24	5384-5388	help	_	_	_	_
30-25	5389-5396	address	_	_	_	_
30-26	5397-5401	many	abstract[269]	new[269]	_	_
30-27	5402-5411	practical	abstract[269]	new[269]	_	_
30-28	5412-5418	issues	abstract[269]	new[269]	_	_
30-29	5419-5421	of	abstract[269]	new[269]	_	_
30-30	5422-5429	concern	abstract[269]|abstract[270]	new[269]|new[270]	_	_
30-31	5430-5432	to	abstract[269]|abstract[270]	new[269]|new[270]	_	_
30-32	5433-5436	the	abstract[269]|abstract[270]|person[271]	new[269]|new[270]|new[271]	_	_
30-33	5437-5443	public	abstract[269]|abstract[270]|person[271]	new[269]|new[270]|new[271]	_	_
30-34	5444-5445	.	_	_	_	_

#Text=Does biking to and from work affect cardiovascular health or indicators of future health outcomes ?
31-1	5446-5450	Does	_	_	_	_
31-2	5451-5457	biking	_	_	_	_
31-3	5458-5460	to	_	_	_	_
31-4	5461-5464	and	_	_	_	_
31-5	5465-5469	from	_	_	_	_
31-6	5470-5474	work	place	new	_	_
31-7	5475-5481	affect	_	_	_	_
31-8	5482-5496	cardiovascular	abstract|abstract[274]	new|giv[274]	coref|coref	31-14[0_274]|31-14[0_274]
31-9	5497-5503	health	abstract[274]	giv[274]	_	_
31-10	5504-5506	or	_	_	_	_
31-11	5507-5517	indicators	abstract[275]	new[275]	_	_
31-12	5518-5520	of	abstract[275]	new[275]	_	_
31-13	5521-5527	future	abstract[275]|abstract[277]	new[275]|giv[277]	_	_
31-14	5528-5534	health	abstract[275]|abstract|abstract[277]	new[275]|giv|giv[277]	_	_
31-15	5535-5543	outcomes	abstract[275]|abstract[277]	new[275]|giv[277]	_	_
31-16	5544-5545	?	_	_	_	_

#Text=Should one limit exercise and biking to the less polluted days or less polluted areas of the city ?
32-1	5546-5552	Should	_	_	_	_
32-2	5553-5556	one	event[279]	giv[279]	_	_
32-3	5557-5562	limit	place|event[279]	new|giv[279]	_	_
32-4	5563-5571	exercise	event[279]	giv[279]	_	_
32-5	5572-5575	and	_	_	_	_
32-6	5576-5582	biking	_	_	_	_
32-7	5583-5585	to	_	_	_	_
32-8	5586-5589	the	time[280]|place[281]	new[280]|new[281]	_	_
32-9	5590-5594	less	time[280]|place[281]	new[280]|new[281]	_	_
32-10	5595-5603	polluted	time[280]|place[281]	new[280]|new[281]	_	_
32-11	5604-5608	days	time[280]|place[281]	new[280]|new[281]	_	_
32-12	5609-5611	or	place[281]	new[281]	_	_
32-13	5612-5616	less	place[281]	new[281]	_	_
32-14	5617-5625	polluted	place[281]	new[281]	_	_
32-15	5626-5631	areas	place[281]	new[281]	_	_
32-16	5632-5634	of	place[281]	new[281]	_	_
32-17	5635-5638	the	place[281]|place[282]	new[281]|new[282]	_	_
32-18	5639-5643	city	place[281]|place[282]	new[281]|new[282]	_	_
32-19	5644-5645	?	_	_	_	_

#Text=Do the health benefits of commuting by bicycle outweigh the costs ?
33-1	5646-5648	Do	_	_	_	_
33-2	5649-5652	the	abstract[283]	new[283]	_	_
33-3	5653-5659	health	abstract[283]	new[283]	_	_
33-4	5660-5668	benefits	abstract[283]	new[283]	_	_
33-5	5669-5671	of	_	_	_	_
33-6	5672-5681	commuting	_	_	_	_
33-7	5682-5684	by	_	_	_	_
33-8	5685-5692	bicycle	object	new	_	_
33-9	5693-5701	outweigh	_	_	_	_
33-10	5702-5705	the	abstract[285]	new[285]	_	_
33-11	5706-5711	costs	abstract[285]	new[285]	_	_
33-12	5712-5713	?	_	_	_	_
